U.S. Markets open in 53 hrs, 32 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 8,280.74 | -223.32 | -2.63% |
| NASDAQ | 1,796.52 | -49.20 | -2.67% |
| S&P 500 | 896.42 | -26.91 | -2.91% |
Experience real-time quotes &
news with the most powerful
iPhone application for investors.
Get the FREE DailyFinance iPhone application
| Day Low | 2.00 03:59 PM EDT | |
|---|---|---|
| Day High | 2.09 09:33 AM EDT |
|
| Range | 0.09 |
| Volume | 74,492 | |
|---|---|---|
| 30-Day Avg Vol | 384,000 |
|
| Difference | -80.60% |
| Market Cap | 74.73 M | |
|---|---|---|
| Mkt Cap Chg | -4.83 M |
| Shares Out | 37.17 M | |
|---|---|---|
| % Shrs Traded | 0.20% | |
| 1yr EPS Est | -1.191 |
| 52-Wk Low | 0.72 11/21/08 | |
|---|---|---|
| 52-Wk High | 3.99 7/8/08 |
|
| Range | 3.27 |
| Prev Close | 2.14 7/1/09 | |
|---|---|---|
| Today's Open | 2.04 | |
| Change | -4.67% |
| Dividend (TTM) | 0.00 | |
|---|---|---|
| Div Yield (TTM) | 0.00% | |
| Ex-Div Date | — | |
| Div Date | — |
|
| Short Interest | 1.31 M |
| Revenue (LFY) | 1.59 M | |
|---|---|---|
| Earnings (LFY) | -64.24 M | |
| Earnings (MRQ) | -15.00 M | |
| Next Earn Est | -0.343 | |
| Next Earnings | 06/10/2009 |
|
| EPS (TTM) | -1.68 | |
| 1yr EPS Growth | 29.53% |
| P/E Ratio (TTM) | — | |
|---|---|---|
| P/E Ratio (Fwd) | -1.00 | |
| PEG Ratio | — | |
| Return on Equity | -76.86 | |
| Beta | 1.94 |
| Sector | Healthcare | |
|---|---|---|
| Industry | Drugs |
above for more info
ACADIA Pharmaceuticals puts genes and drugs together to fight disease. The development-stage company uses its proprietary R-SAT technology to identify and evaluate genomic targets for drug therapies, primarily ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| Next Quarter | -0.343 N/A | — — |
—
—
|
| Last Quarter | -0.358 3/31/09 | -0.40 3/31/09 |
-0.042
Missed
|
| 2 Quarters Ago | -0.374 12/31/08 | -0.38 12/31/08 |
-0.006
Missed
|
| Quarterly - 03/31/2009 | Annual - 2008 | |
|---|---|---|
| Total Revenue | 374,000.00 | 1.59 M |
| Gross Profit | -4.70 M | 547,000.00 |
| Operating Income | -15.17 M | -64.82 M |
| Net Income | -15.00 M | -64.24 M |
Notices and Terms: Confirm all data with your broker before trading.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Quote data provided by Interactive Data. Real-Time prices provided by BATS. Historical prices provided by Prophet. Company Profile provided by Hoovers. Executive data and Industry/Sector information provided by Morningstar Inc. Earnings, Ownership, Financial Statement, Insider Trading, Conference Call schedules and SEC Filing information provided by Thomson Reuters.
Advanced Chart
Technical Charts